Non-parenteral formulation of Remdesivir for Covid-19 treatment
Remdesivir exhibits in vitro activity against SARS-CoV-2 and was granted approval for Emergency Use. To maximize delivery to the lungs,
A forum for researchers, students and applicants in the field of cyclodextrin technology
Remdesivir exhibits in vitro activity against SARS-CoV-2 and was granted approval for Emergency Use. To maximize delivery to the lungs,
The plasma membrane microdomain lipid rafts have been found by researchers to be involved in the replication cycle of numerous
CycloLab’s submission to InnoCentive Challenge 9934291 – New Technologies to Prevent the Transmission of Coronavirus led to a favorable evaluation.
Obesity has become a worldwide health crisis and is associated with a plethora of comorbidities. Cardiovascular disease (CVD) and type
„Inhaled nitric oxide dilates or widens arteries to allow more blood to flow through the lungs. It also relaxes the
Strategic drug repurposing in combination with rapid testing of established molecular targets could provide a pause in disease progression and
Gilead’s Investigational Antiviral Veklury® (Remdesivir) Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of Patients With
Hielscher Ultrasonics shows on its website how remdesivir solution can be easily prepared by complexation with sulfobutyl ether beta-cyclodextrin using
The systematic review published recently in Clinical Microbiology and Infection was based on 29 articles [1]. All studies except one
Vitamin D deficiency or insufficiency is very common in the general population as well as in patients with COVID-19. It